Gary Bean, MD
Family Medicine · Raleigh, NCNPI 1760452312
Payments from drug & device makers
Across 466 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$917
- Lilly USA, LLC$835
- Boehringer Ingelheim$662
- Chugai Pharmaceutical Co., Ltd.$500
- AstraZeneca$424
- plus $4K from 41 others
What the payments were for
- Consulting fees$1,10814%
- Food & beverage$7,00086%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Skyrizi$300
How this compares
$8,120 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 65 | $73,159 |
| MounjaroTirzepatide | 48 | $51,933 |
| OzempicSemaglutide | 48 | $48,726 |
| EliquisApixaban | 30 | $37,420 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 87 | $26,990 |
| JanuviaSitagliptin Phosphate | 20 | $22,440 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $11,879 |
| XareltoRivaroxaban | 17 | $11,037 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $10,338 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $6,392 |
| SynthroidLevothyroxine Sodium | 50 | $5,781 |
| ZanaflexTizanidine Hcl | 13 | $3,848 |
| Gabapentin | 114 | $3,645 |
| Atorvastatin Calcium | 274 | $3,067 |
| Rosuvastatin Calcium | 204 | $2,579 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $662 | $73,15965 claims |
| Lilly USA, LLCMounjaro | $835 | $51,93348 claims |
| Novo NordiskOzempic | $1,002 | $48,72648 claims |
| PfizerEliquis | $379 | $37,42030 claims |
| GSKArexvy | $300 | $26,99087 claims |
| MerckJanuvia | $112 | $22,44020 claims |
| Johnson & JohnsonXarelto | $365 | $11,03717 claims |
| AstraZenecaSymbicort | $424 | $6,39216 claims |
| AbbVieSynthroid | $917 | $5,78150 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $31 | $2,513182 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Raleigh
- William CromwellRaleigh$2.7M
- Andrew DrabickRaleigh$289K
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.